John Paget

John Paget, PhD, has worked as an infectious disease epidemiologist for the last 20 years, first at WHO (Geneva), then the Swiss Federal Office of Public Health (Bern, Switzerland) and now at Netherlands Institute for Health Services Research (NIVEL).

He currently also holds a part-time position at AMPHI, where he is working on Q fever and MRSA. He has an MSc in Medical Demography from the London School of Hygiene and Tropical Medicine and a PhD in Epidemiology from the Swiss Tropical Institute at the University of Basel.

He was the project leader of the European Influenza Surveillance Scheme from 2000 to 2008 and has worked on the epidemiology and surveillance of influenza in Europe for the past 12 years. At NIVEL, he is the Project Leader of the EC-funded APRES (Appropriateness of Prescribing Antibiotics in Primary Health Care in Europe) and WHO-funded GLaMOR (Global Pandemic Mortality Burden) projects.

CV

  • October 2012 – 31 December 2018. Associate Editor, BMC Infectious Diseases
  • September 2009 – 17 mei 2017. Senior Researcher (Epidemiologist), Radboud University Medical School, Department of Public Health, Nijmegen [http://www.academischewerkplaatsamphi.nl/Medewerkers/Algemeen] (Part-time position – 1 day per week). Areas of activity: Q fever and MRSA. Infectious disease surveillance teaching as of 2011.
  • September 2008 – present. Senior Researcher, Netherlands Institute for Health Care Research (Nivel).
  • Member of the Steering Committee, Global Influenza Initiative (GII), 2015-2018
  • Co-Chair of the Global Influenza and RSV Initiative (GIRI), 2018-present
  • Member of the Independent Scientific Committee, Global Influenza Hospitalization Surveillance Network, Paris, France, 2017-present
  • Member of the Executive Committee, Foundation for Influenza, Paris, France, 2017-present

Current activities at Nivel:

  • Project Leader, Estimating the Global 2009 H1N1 Pandemic Mortality Burden (GLaMOR). Project funded by WHO HQ [since 1 July 2011]
  • Project Leader, The appropriateness of prescribing antibiotics in primary care in Europe related to antibiotic resistance (APRES) ; see: www.nivel.eu/apres for full description of this project [since September 2009]
  • Steering Committee Member, Influenza B General Practitioners (IBGP), project co-ordinated by Open Rome, Paris, France [since 2009]

Previous activities at Nivel:

  • 2009 - December 2011: European Co-ordinator of the European Paediatric Influenza Analysis project – EPIA (2009-2011)
  • October 2008 - December 2011: September Advisor supporting WHO Euro (http://www.euroflu.org) with the surveillance of influenza in non-EU countries in the Europe Region. Included the preparation of a WHO guideline document for the surveillance of influenza in Europe (2008-2011).
  • April 2000 – September 2008. Senior Researcher, Netherlands Institute for Health Care Research (Nivel). Project leader and co-ordinator of the European Influenza Surveillance Scheme (EISS) [EISS is now based at ECDC].
  • January 1992 - March 2000. Epidemiologist, Swiss Federal Office of Public Health, Bern Switzerland.
  • February 1989 - December 1991.Technical Officer, Global Programme on AIDS, World Health Organisation, Geneva, Switzerland.